INTERNATIONAL PATENT: INFLAMAX PHARMACEUTICALS LIMITED, 安炎达医药技术（广州）有限公司 FILES APPLICATION FOR "NOVEL PACE4 INHIBITOR AND USE THEREOF IN ANTI-OSTEOARTHRITIS"

GENEVA, May 16 -- INFLAMAX PHARMACEUTICALS LIMITED (Rm 801, 15th Bld, 188 Kaiyuan Ave, Huangpu DistrictGuangzhou, Guangdong 510530), 安炎达医药技术（广州）有限公司 (中国广东省广州市黄埔区开源大道188号十五栋801房) filed a patent application (PCT/CN2024/090607) for "NOVEL PACE4 INHIBITOR AND USE THEREOF IN ANTI-OSTEOARTHRITIS" on Apr 29, 2024. With publication no. WO/2025/097674, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Clas...